BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • BioTech Events
  • BioTech Company Directory
  • Contact Us
Archives
  • May 2023
  • August 2021
  • July 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • BioTech Events
  • BioTech Company Directory
  • Contact Us

BioTech Health X

43 posts
Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
BioTech Health X
  • May 31, 2023

Biotech NewsKrystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial

  • 3 minute read
Leader in redosable gene therapy Krystal Biotech, Inc. (NASDAQ: KRYS) announced today the United States Food and Drug…
0 Shares
0
0
0
0
0
0
0
Advanced Chemotherapy Technologies Receives 4 Million NIH Grant to Pursue Pancreatic Cancer Treatment
BioTech Health X
  • May 31, 2023

Biotech NewsAdvanced Chemotherapy Technologies Receives $4 Million NIH Grant to Pursue Pancreatic Cancer Treatment

  • 3 minute read
Clinical-stage drug delivery company Advanced Chemotherapy Technologies (ACT) announced that the company has been awarded a Phase IIb…
0 Shares
0
0
0
0
0
0
0
Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
BioTech Health X
  • May 31, 2023

Biotech NewsMerck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial

  • 3 minute read
Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating…
0 Shares
0
0
0
0
0
0
0
Cel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head Neck Patients in Phase 3 Trial
BioTech Health X
  • May 31, 2023

Biotech NewsCel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head & Neck Patients in Phase 3 Trial

  • 3 minute read
Data Shows Significant Overall Survival Benefit for Cancer Patients with Multikine Treatment Regimen Followed by Surgery & Radiotherapy…
0 Shares
0
0
0
0
0
0
0
ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
BioTech Health X
  • May 31, 2023

Biotech NewsImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug

  • 3 minute read
In breaking news, clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX) has announced acceptance by the FDA review of…
0 Shares
0
0
0
0
0
0
0
BioTech Health X
  • May 30, 2023

Uncategorized11/19/21

  • 5 minute read
BioTech Health X Ortho Clinical Diagnostics Overview & Q&A Michael S. Iskra, Executive Vice President of Commercial Excellence…
0 Shares
0
0
0
0
0
0
0
Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery T Cell Receptors
BioTech Health X
  • May 29, 2023

Biotech NewsRepertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors

  • 3 minute read
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…
2 Shares
2
0
0
0
0
0
0
Inhibikase-Therapeutics-Present-Phase-1-1b-Trial-Results-ADPD-Alzheimers-Parkinsons-Diseases-Conference
BioTech Health X
  • May 28, 2023

Biotech NewsInhibikase Therapeutics To Present Phase 1/1b Trial Results at AD/PD Alzheimer’s & Parkinson’s Diseases Conference

  • 3 minute read
Clinical-stage pharmaceutical company Inhibikase Therapeutics, Inc. (Nasdaq: IKT) recently announced that President and CEO Dr. Milton Werner, Ph.D. will be…
0 Shares
0
0
0
0
0
0
0
Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results
BioTech Health X
  • May 28, 2023

Biotech NewsVirios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results

  • 5 minute read
In a shocking failure, Virios Therapeutics announced this morning pre-market that topline results from its FORTRESS (Fibromyalgia Outcome…
0 Shares
0
0
0
0
0
0
0
BioTech Health X CEO Series Virios Therapeutics Greg Duncan
BioTech Health X
  • May 28, 2023

BioTech CEO InterviewsBioTech Health X CEO Series: Virios Therapeutics Greg Duncan

  • 7 minute read
BioTech Health X works to deliver the latest coverage and updates in the biotechnology sector. This includes providing…
0 Shares
0
0
0
0
0
0
0
Stevanato Announces Proposed Initial Public Offering IPO
BioTech Health X
  • May 28, 2023

Biotech NewsStevanato Announces Proposed Initial Public Offering (IPO)

  • 2 minute read
Stevanato, the Italian family-owned yet global manufacturer and provider of drug containment, drug delivery and diagnostic solutions, has…
0 Shares
0
0
0
0
0
0
0
Oracle-Health-Republic-Y-Combinator
BioTech Health X
  • May 28, 2023

Biotech NewsOracle Health Raises $2.7M from Investors, Turns Down Y Combinator Funding

  • 3 minute read
Innovative medtech company Oracle Health has raised over $2.7 Million from investors through the Republic platform. The company…
0 Shares
0
0
0
0
0
0
0
Infinity Pharmaceuticals Add 2 New Members to Board of Directors
BioTech Health X
  • May 27, 2023

Biotech NewsInfinity Pharmaceuticals Add 2 New Members to Board of Directors

  • 3 minute read
Clinical-stage biotech Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced the change of 2 new Board of Directors roles including…
0 Shares
0
0
0
0
0
0
0
CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
BioTech Health X
  • May 27, 2023

Biotech NewsCEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022

  • 8 minute read
CEL-SCI recently presented its Phase 3 data at ESMO 2022, which revealed that Neoadjuvant Multikine achieved groundbreaking tumor…
0 Shares
0
0
0
0
0
0
0
Capricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update
BioTech Health X
  • May 27, 2023

Biotech NewsCapricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update

  • 3 minute read
May 13 is a busy day for biotechnology company Capricor Therapeutics (NASDAQ: CAPR). The company which focuses on…
0 Shares
0
0
0
0
0
0
0
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive - Virology Experts Weigh In
BioTech Health X
  • May 27, 2023

Biotech NewsCOVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive – Virology Experts Weigh In

  • 3 minute read
Professional Major League Baseball organization the New York Yankees have been rocked this week with COVID-19 after 8…
0 Shares
0
0
0
0
0
0
0
NTx Hires Bristol-Myers Squibb Veteran Biopharma Executive Nancy Rurkowski to Join its Board of Directors
BioTech Health X
  • May 26, 2023

Biotech NewsNTx Hires Bristol-Myers Squibb Veteran Biopharma Executive Nancy Rurkowski to Join its Board of Directors

  • 2 minute read
The 35-year veteran of Bristol-Myers Squibb brings manufacturing operations and product launch leadership expertise to drive NTx commercialization…
0 Shares
0
0
0
0
0
0
0
Xontogeny-CEO-Chris-Garabedian-Interiew-BioTech-Health-X
BioTech Health X
  • May 26, 2023

BioTech CEO InterviewsXontogeny CEO Chris Garabedian Exclusive Interview [September 2021]

  • 5 minute read
As we expand our coverage of the biotechnology sector with the latest biotech news, our team at BioTech…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
  • Advanced Chemotherapy Technologies Receives $4 Million NIH Grant to Pursue Pancreatic Cancer Treatment
  • Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
  • Cel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head & Neck Patients in Phase 3 Trial
  • Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle (PTV)
Recent Comments
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz MichaƂowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • May 31, 2023
    Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
    Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
    • May 31, 2023
    Advanced Chemotherapy Technologies Receives $4 Million NIH Grant to Pursue Pancreatic Cancer Treatment
    Advanced Chemotherapy Technologies Receives 4 Million NIH Grant to Pursue Pancreatic Cancer Treatment
    • May 31, 2023
    Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
    Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
    • May 31, 2023
    Cel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head & Neck Patients in Phase 3 Trial
    Cel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head Neck Patients in Phase 3 Trial
    • May 31, 2023
    Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle (PTV)
    Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle PTV
Recent Posts
  • 2021 William Blair Biotech Conference
    Presenters Announced for 2021 William Blair Biotech Conference
    • May 28, 2023
  • Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital
    Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital
    • May 27, 2023
  • BenchSci Expands Advisory Board with New Pharma R&D Leaders
    BenchSci Expands Advisory Board with New Pharma R&D Leaders
    • May 26, 2023
Categories
  • BioTech CEO Interviews (4)
  • Biotech Info (1)
  • Biotech News (45)
  • Uncategorized (1)
BioTech Health X
Designed & Developed by Code Supply Co.
  • Our Contributors
  • List of Modern Life Science Technologies
  • Contact Us
Back to top